| Poly(luminol)/nano-ZnO |
Ascorbic acid (vitamin C) |
1 × 10−6 M |
GCE |
47
|
| Poly(luminol–benzidine) |
H2O2
|
6 × 10−11 M |
Graphite electrode |
48
|
| Poly(luminol) |
H2O2
|
— |
Screen-printed electrodes (SPEs) |
49
|
| Choline |
| Poly(luminol–aniline) nanowires composite (PLANC) |
Glucose |
3 × 10−8 M |
Graphite electrode |
50
|
| Copolymerization of luminol in the presence of different monomers |
H2O2
|
2.6 × 10−9 M |
Screen-printed gold electrode (gold SPE) |
51
|
| Gold nanoparticles-poly(luminol) (Plu-AuNPs)/MWCNTs |
Dopamine (DA) |
1.9 × 10−7 M (DA) |
GCE |
52
|
| Uric acid (UA) |
3.8 × 10−7 M (UA) |
| Poly(luminol–biotinylated pyrrole) |
Cholesterol |
1.47 × 10−5 M |
Gold screen-printed cells |
53
|
| Poly(luminol) |
Free chlorine content in drinking water |
5 × 10−7 M |
Planar indium-tin-oxide (ITO) electrode |
54
|
| Poly(aniline–luminol) |
Flow-injection-analysis (FIA) |
1.0 × 10−12 g |
AuAg/TiO2 nanohybrid functionalized indium tin oxide coated glass |
55
|
| Poly(luminol) and poly(neutral red)/GO/(MWCNTs) |
β-Nicotinamide adenine dinucleotide [NADH] |
1.33 × 10−8 M |
GCE |
56
|
| Poly(luminol–benzidine sulfate) |
Dopamine |
5 × 10−10 M |
Fluorine-doped tin oxide (FTO) glass |
57
|
| Poly(aniline–luminol)/GO nanocomposite |
Alpha-fetoprotein (AFP) |
5 × 10−13 mg mL−1
|
Chemical polymerization using (NH4)2S2O8
|
58
|
| Poly(luminol)/(f-MWCNTs) |
Paracetamol |
2.5 × 10−8 M |
GCE |
59
|
| Poly(aniline–luminol–hemin) nanocomposites |
Choline |
1.2 × 10−12 M |
Graphite electrode |
60
|
| Poly(aniline–luminol)/MWCNTs |
The assay of hepatitis B virus (HBV) DNA |
2.4 × 10−17 M |
Graphite electrode |
61
|